Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiyue Hu

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Scientific Reports|April 29, 2021
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasisSuxing Liu, Dong Liu, Ru Shen, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase InhibitorsWangyang Tu, Fanglong Yang, Guoji Xu, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2016
WITHDRAWN: Discovery of SHR1977: A highly potent and selective ROMK inhibitorXin Li, Yun Zhang, Yang Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2014
Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitorsHejun Lu, Wangyang Tu, Hongbo Fei, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancerPeng Zhao, Xiangzhu Wang, Linghang Zhuang, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2016
Discovery of EBI-907: A highly potent and orally active B-Raf(V600E) inhibitor for the treatment of melanoma and associated cancersBiao Lu, Hu Cao, Jingsong Cao, et al.
Oncotargets and Therapy|September 1, 2021
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast CancerSuxing Liu, Di Li, Jian Liu, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 InhibitorsFangfang Jin, Qiyue Hu, Hongbo Fei, et al.
Journal of Medicinal Chemistry|September 25, 2007
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitorsMin Teng, Jinjiang Zhu, Michael D Johnson, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2010
PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compoundsZhengwei Peng, Bo Yang, Sarathy Mattaparti, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Scientific Reports|April 29, 2021
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasisSuxing Liu, Dong Liu, Ru Shen, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase InhibitorsWangyang Tu, Fanglong Yang, Guoji Xu, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2016
WITHDRAWN: Discovery of SHR1977: A highly potent and selective ROMK inhibitorXin Li, Yun Zhang, Yang Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2014
Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitorsHejun Lu, Wangyang Tu, Hongbo Fei, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancerPeng Zhao, Xiangzhu Wang, Linghang Zhuang, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2016
Discovery of EBI-907: A highly potent and orally active B-Raf(V600E) inhibitor for the treatment of melanoma and associated cancersBiao Lu, Hu Cao, Jingsong Cao, et al.
Oncotargets and Therapy|September 1, 2021
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast CancerSuxing Liu, Di Li, Jian Liu, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 InhibitorsFangfang Jin, Qiyue Hu, Hongbo Fei, et al.
Journal of Medicinal Chemistry|September 25, 2007
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitorsMin Teng, Jinjiang Zhu, Michael D Johnson, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2010
PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compoundsZhengwei Peng, Bo Yang, Sarathy Mattaparti, et al.
Pageof 5